ArticleNeuropharmacology2007

Antinociception mediated by alpha(2)-adrenergic activation involves increasing tumor necrosis factor alpha (TNFalpha) expression and restoring TNFalpha and alpha(2)-adrenergic inhibition of norepinephrine release.

Robert N Spengler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.